Browsing Tag
RNAi therapeutics
3 posts
Can RNA interference expand beyond rare diseases through Tenaya–Alnylam cardiovascular research? (NASDAQ: ALNY, NASDAQ: TNYA)
Tenaya Therapeutics and Alnylam Pharmaceuticals partner to discover RNAi drug targets for cardiovascular disease. Read what this biotech deal could mean.
Phio’s INTASYL therapy PH-762 shows 100% tumor clearance in skin cancer dose-escalation study
Find out how Phio Pharmaceuticals’ RNAi-based PH-762 achieved high tumor clearance in a skin cancer study and what it could mean for non-surgical treatment paths today!
OliX Pharmaceuticals seeks FDA nod for phase 2a trial of OLX10010
OliX Pharmaceuticals, a South Korean pharma company, has submitted an investigational new drug (IND) application to the US…